Show simple item record

dc.contributor.authorAydemir, Levent
dc.contributor.authorIplik, Elif Sinem
dc.contributor.authorErtugrul, Baris
dc.contributor.authorKasarci, Goksu
dc.contributor.authorAtas, Merve Nur
dc.contributor.authorUlusan, Murat
dc.contributor.authorErgen, Arzu
dc.contributor.authorCakmakoglu, Bedia
dc.date.accessioned2021-12-21T08:45:54Z
dc.date.available2021-12-21T08:45:54Z
dc.date.issued2021
dc.identifier.issn1357-0560
dc.identifier.issn1559-131X
dc.identifier.urihttps://doi.org/10.1007/s12032-021-01538-2
dc.identifier.urihttp://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1819
dc.description.abstractOral squamous cell carcinoma patients are exhausted against the powerful chemotherapies, radiotherapies after the surgery, and their immune system is devastated during the process and antibiotic usage become inescapable. Although prescribing an antibiotic
dc.description.sponsorshipScientific Research Projects Coordination Unit of Istanbul University in Istanbul, Turkey [24114]
dc.language.isoEnglish
dc.publisherHumana Press Inc
dc.titleLevofloxacin might be safe to use for OSCC patients
dc.typeArticle
dc.relation.journalMedıcal Oncology
dc.identifier.issue8
dc.identifier.volume38
dc.identifier.doi10.1007/s12032-021-01538-2
dc.relation.issue8
dc.relation.volume38


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record